Moneycontrol PRO
Loans
HomeAuthorLekha badlani

Lekha Badlani

Research Analyst

Money Control

Medanta: Still more to offer

BUSINESS

Medanta: Still more to offer

Medanta has a solid footing in the NCR region and is focused on widening its reach in the underserved Tier II markets

Merger with MCFL to add pace to Paradeep Phosphates’ marathon run

BUSINESS

Merger with MCFL to add pace to Paradeep Phosphates’ marathon run

The proposed combined entity is likely to emerge as a pan-India fertiliser company.

Entero IPO: Should investors pop the flotation pill?

BUSINESS

Entero IPO: Should investors pop the flotation pill?

The company will have to scale up its top line manifold to be able to protect its profitability

Consumption, agriculture sectors in the spotlight, post interim Budget

BUSINESS

Consumption, agriculture sectors in the spotlight, post interim Budget

Rural recovery looks imminent on the back of higher government spending and lower inflation

Modi's Budget keeps agrochem sector on a fertile pitch

BUSINESS

Modi's Budget keeps agrochem sector on a fertile pitch

Some much needed initiatives announced by the government for the agriculture sector

Tata Steel: Europe losses bottom out, India to drive earnings

BUSINESS

Tata Steel: Europe losses bottom out, India to drive earnings

Chinese imports will play a bigger role in determining steel prices

JSW Steel: Proxy play to higher volume growth

BUSINESS

JSW Steel: Proxy play to higher volume growth

JSW Steel is the best placed among peers, in terms of volume growth

Nova Agritech IPO: Hunting for high growth capital, eyes ‘one-stop solution provider’ tag

BUSINESS

Nova Agritech IPO: Hunting for high growth capital, eyes ‘one-stop solution provider’ tag

The sustainability of margins and the growth trajectory will be key factors to watch

Should investors subscribe to Medi Assist IPO?

BUSINESS

Should investors subscribe to Medi Assist IPO?

The bulk of the TPA’s revenue is linked to the premium under management of health insurers

Budget 2024: Off-radar agrochem may take centre-stage

BUSINESS

Budget 2024: Off-radar agrochem may take centre-stage

With the budget and election this year, agriculture will remain a talking point

KIMS: Why we remain on the sidelines

BUSINESS

KIMS: Why we remain on the sidelines

KIMS is well-positioned to seize the growing demand for healthcare facilities in the country. Timely execution and ramp-up of new projects will be key.

The two tales of the agrochemical market

BUSINESS

The two tales of the agrochemical market

The domestic agrochemical market is better placed while issues persist on export front

Innova Captab IPO: A pricey contract manufacturer

BUSINESS

Innova Captab IPO: A pricey contract manufacturer

The prime driver of growth is the volume visibility from contract duration, which is typically in the range of 2-5 years

Credo (Mufti) IPO: Should you wear this fashion brand?

BUSINESS

Credo (Mufti) IPO: Should you wear this fashion brand?

Despite mediocre top-line growth, Mufti has managed to show impressive growth in profitability

PI Industries: Is value emerging or is it time to panic?

BUSINESS

PI Industries: Is value emerging or is it time to panic?

Pyroxasulfone has huge market demand and, given the patent protection for the next few years, we see limited impact on PI’s growth story

Max Healthcare: Should good health come at a cost?

BUSINESS

Max Healthcare: Should good health come at a cost?

Expansion plan supports growth momentum; however, valuations have turned quite high.

Margins of Krsnaa Diagnostics catch a flu

BUSINESS

Margins of Krsnaa Diagnostics catch a flu

The general health of the company is intact with a solid, differentiated business model and promising growth potential

There are more steps to Medanta’s growth ladder

BUSINESS

There are more steps to Medanta’s growth ladder

Demand for high-end healthcare facilities remains strong and Medanta is strategically cementing its footprint in north India.

Honasa Consumers: Impressive Q2, but sustainability key to re-rating

BUSINESS

Honasa Consumers: Impressive Q2, but sustainability key to re-rating

While the company has shown impressive revenue growth in the last two years and in H1FY24, we think after reaching a high base of Rs 960 crore in the first half, it would be difficult to grow at the same pace.

Vijaya Diagnostic Centre: How does it stand out in a crowded space?

BUSINESS

Vijaya Diagnostic Centre: How does it stand out in a crowded space?

A steady growth profile, strong regional presence, and a higher focus on radiology give the company an edge in a highly competitive industry

These two fertiliser stocks are marathon runners

BUSINESS

These two fertiliser stocks are marathon runners

Coromandel International and Paradeep Phosphates have multiple value-accretive catalysts.

Apollo Hospitals: Profitability of non-hospital businesses a key watch

BUSINESS

Apollo Hospitals: Profitability of non-hospital businesses a key watch

A credible profitability roadmap for pharmacy is the ask

PI Industries sticks with its growth momentum

BUSINESS

PI Industries sticks with its growth momentum

PI Industries, with superior execution and a solid business model, is on track to achieve its long-term strategic objectives

ASK Automotive IPO: Should you subscribe to this growth story?

BUSINESS

ASK Automotive IPO: Should you subscribe to this growth story?

The growing need for safety systems in the automotive sector is expected to increase the demand for efficient brake components

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347